{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3481, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-2e64-754b-ae3d-102d7aafb97f", "docSlug": "37acdc1404033fc1280ba03c6bcdbf9d", "documentTitle": "Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 10, "slideType": "villain_critique", "function": "name_villain", "notes": "Uses a combination of a donut chart for ownership and bar/line charts for financial performance to discredit the target company.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2e64-754b-ae3d-102d7aafb97f/10", "deckHref": "/decks/019de075-2e64-754b-ae3d-102d7aafb97f", "deckAnchorHref": "/decks/019de075-2e64-754b-ae3d-102d7aafb97f#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "c23072c2-16fd-4a21-845a-10a0d2eed48d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The deck exposes contradictions and critiquing villains, making the alternatives appear less appealing", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2e64-754b-ae3d-102d7aafb97f", "docSlug": "37acdc1404033fc1280ba03c6bcdbf9d", "documentTitle": "Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 11, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Uses a 'Claim vs Reality' framework to discredit competitors' M&A strategies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2e64-754b-ae3d-102d7aafb97f/11", "deckHref": "/decks/019de075-2e64-754b-ae3d-102d7aafb97f", "deckAnchorHref": "/decks/019de075-2e64-754b-ae3d-102d7aafb97f#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 11, "beatId": "0ad92eba-4699-4e09-b0b4-5ce04dfb21c7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Nano Dimension's offer as the solution, providing relief to Stratasys shareholders", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2e64-754b-ae3d-102d7aafb97f", "docSlug": "37acdc1404033fc1280ba03c6bcdbf9d", "documentTitle": "Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 12, "slideType": "comparison_table", "function": "compare_peers", "notes": "Uses a hub-and-spoke style layout to position Nano Dimension as the superior option against two competitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2e64-754b-ae3d-102d7aafb97f/12", "deckHref": "/decks/019de075-2e64-754b-ae3d-102d7aafb97f", "deckAnchorHref": "/decks/019de075-2e64-754b-ae3d-102d7aafb97f#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 11, "beatId": "0ad92eba-4699-4e09-b0b4-5ce04dfb21c7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Nano Dimension's offer as the solution, providing relief to Stratasys shareholders", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/zx84YTFAO4GfLCd9WElMDLNcEOKJsgd8Nc8Ekxf7kzk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kN2FiYjg0ZGUyYmY2ZWM2NzU5ZDczODc5M2UwNTAyZS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/1", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "dba91716-2dd7-4102-a67a-a93143110e04", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Current State", "beatSlug": "sparkline-what-is-1", "evidence": "Slides 1-5 introduce the company and its current performance", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/0oCh-owuFOxB-JP4k2980yClNt1CVAsZqix5swHJZUM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kN2FiYjg0ZGUyYmY2ZWM2NzU5ZDczODc5M2UwNTAyZS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/lf8wgl7Y0fRAV7HJDMWnhkh3FkMEGVd994HbxU550ik/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kN2FiYjg0ZGUyYmY2ZWM2NzU5ZDczODc5M2UwNTAyZS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/QyTM8DTYROJD6ik7zOwfWlBbqKc6NoFeMUj1hDqX9dE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kN2FiYjg0ZGUyYmY2ZWM2NzU5ZDczODc5M2UwNTAyZS9wMDAxLnBuZw" }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/2", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "dba91716-2dd7-4102-a67a-a93143110e04", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Current State", "beatSlug": "sparkline-what-is-1", "evidence": "Slides 1-5 introduce the company and its current performance", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/3", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "dba91716-2dd7-4102-a67a-a93143110e04", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Current State", "beatSlug": "sparkline-what-is-1", "evidence": "Slides 1-5 introduce the company and its current performance", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes IFRS and non-IFRS financial metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/4", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "dba91716-2dd7-4102-a67a-a93143110e04", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Current State", "beatSlug": "sparkline-what-is-1", "evidence": "Slides 1-5 introduce the company and its current performance", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes non-IFRS adjustments and footnotes regarding reconciliation and expense exclusions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/5", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-5", "loopMatches": [ { "to": 6, "from": 5, "name": "Zoom In", "slug": "06-zoom-in", "bestFor": "Technical deep-dives, case studies, detailed analysis", "matchId": "b0e97f68-ad41-44d0-a705-68a2781dd8b9", "evidence": "Slides 5-6 provide a detailed look at financial performance", "position": 1, "objective": "Zoom in on key financial metrics", "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication", "confidence": 0.6, "description": "Start broad, then progressively focus on specific details that prove your point" } ], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "dba91716-2dd7-4102-a67a-a93143110e04", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Current State", "beatSlug": "sparkline-what-is-1", "evidence": "Slides 1-5 introduce the company and its current performance", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes IFRS vs non-IFRS reconciliation notes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/6", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-6", "loopMatches": [ { "to": 6, "from": 5, "name": "Zoom In", "slug": "06-zoom-in", "bestFor": "Technical deep-dives, case studies, detailed analysis", "matchId": "b0e97f68-ad41-44d0-a705-68a2781dd8b9", "evidence": "Slides 5-6 provide a detailed look at financial performance", "position": 1, "objective": "Zoom in on key financial metrics", "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication", "confidence": 0.6, "description": "Start broad, then progressively focus on specific details that prove your point" } ], "arcBeatMatches": [ { "to": 12, "from": 6, "beatId": "64f0e5ff-21ee-4695-bec9-eae108044d73", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Future Vision", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 6-12 present growth strategies and future prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart includes a trend line and percentage growth annotations between periods.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/7", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 6, "beatId": "64f0e5ff-21ee-4695-bec9-eae108044d73", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Future Vision", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 6-12 present growth strategies and future prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart highlights Nano Dimension's superior performance (43%) compared to negative or low growth among peers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/8", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 6, "beatId": "64f0e5ff-21ee-4695-bec9-eae108044d73", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Future Vision", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 6-12 present growth strategies and future prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses logos of acquired companies to represent the growth of the parent entity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/9", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-9", "loopMatches": [ { "to": 10, "from": 9, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "7069e64b-a59f-4c91-bf8d-87e6815cbcb4", "evidence": "Slides 9-10 present before-and-after comparisons", "position": 0, "objective": "Highlight M&A synergies and sales wins", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 12, "from": 6, "beatId": "64f0e5ff-21ee-4695-bec9-eae108044d73", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Future Vision", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 6-12 present growth strategies and future prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide uses a bar chart to show revenue growth and a secondary callout box to compare against a competitor's performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/10", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-10", "loopMatches": [ { "to": 10, "from": 9, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "7069e64b-a59f-4c91-bf8d-87e6815cbcb4", "evidence": "Slides 9-10 present before-and-after comparisons", "position": 0, "objective": "Highlight M&A synergies and sales wins", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 12, "from": 6, "beatId": "64f0e5ff-21ee-4695-bec9-eae108044d73", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Future Vision", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 6-12 present growth strategies and future prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/11", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 6, "beatId": "64f0e5ff-21ee-4695-bec9-eae108044d73", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Future Vision", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 6-12 present growth strategies and future prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "closing_ask", "function": "state_demand", "notes": "The slide serves as a call to action for shareholders to tender their shares.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/12", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 6, "beatId": "64f0e5ff-21ee-4695-bec9-eae108044d73", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Future Vision", "beatSlug": "sparkline-what-could-be-2", "evidence": "Slides 6-12 present growth strategies and future prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/13", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 13, "beatId": "85d7da4a-ec3a-4182-9185-723f8fa0546d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Conclusion", "beatSlug": "sparkline-new-bliss", "evidence": "Slides 13-18 summarize key takeaways and provide additional information", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/14", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 13, "beatId": "85d7da4a-ec3a-4182-9185-723f8fa0546d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Conclusion", "beatSlug": "sparkline-new-bliss", "evidence": "Slides 13-18 summarize key takeaways and provide additional information", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard financial disclosure slide defining non-GAAP/non-IFRS metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/15", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 13, "beatId": "85d7da4a-ec3a-4182-9185-723f8fa0546d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Conclusion", "beatSlug": "sparkline-new-bliss", "evidence": "Slides 13-18 summarize key takeaways and provide additional information", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes reconciliation for EBITDA, Adjusted EBITDA, Adjusted Gross Profit, and Net Cash used in operations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/16", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 13, "beatId": "85d7da4a-ec3a-4182-9185-723f8fa0546d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Conclusion", "beatSlug": "sparkline-new-bliss", "evidence": "Slides 13-18 summarize key takeaways and provide additional information", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart illustrates the ratio of cash balance to annual net cash used in operating activities, highlighting Nano Dimension's superior liquidity position.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/17", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 13, "beatId": "85d7da4a-ec3a-4182-9185-723f8fa0546d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Conclusion", "beatSlug": "sparkline-new-bliss", "evidence": "Slides 13-18 summarize key takeaways and provide additional information", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2eff-7780-b097-688504bdc0b7", "docSlug": "d7abb84de2bf6ec6759d738793e0502e", "documentTitle": "Nano Dimension | Results Presentation Deck | 18 slides", "authorId": "nano-dimension", "authorName": "Nano Dimension", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes regarding IFRS reconciliation and specific line item definitions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2eff-7780-b097-688504bdc0b7/18", "deckHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7", "deckAnchorHref": "/decks/019de075-2eff-7780-b097-688504bdc0b7#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 13, "beatId": "85d7da4a-ec3a-4182-9185-723f8fa0546d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Conclusion", "beatSlug": "sparkline-new-bliss", "evidence": "Slides 13-18 summarize key takeaways and provide additional information", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Features a 3D rendering of a synapse.", "imagePath": "https://imgproxy.kitesheet.com/aN2_70XA0ujdlHOK67dKJlLcnK2BfFL79qjeRcRwMb0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZTQwN2JiYWU4ZjllMDA1YzNmNzI2OGFlYTJiNGYxMy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/1", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/_5G1quy3Ctrk72vcXGVlacXVWwY6-PfoFFPL5Stjc7Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZTQwN2JiYWU4ZjllMDA1YzNmNzI2OGFlYTJiNGYxMy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/QOQPkWTSkvQQPtMk94qJ1B38nuC42VflDHL0nHtqkLM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZTQwN2JiYWU4ZjllMDA1YzNmNzI2OGFlYTJiNGYxMy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/jFc0_DL6eT17ICbcfxTtbkEYaTDDBkyCBIZl_Gqi1Zc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZTQwN2JiYWU4ZjllMDA1YzNmNzI2OGFlYTJiNGYxMy9wMDAxLnBuZw" }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/2", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a standard drug development pipeline visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/3", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a progress bar at the bottom indicating 'Intro' section.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/4", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-4", "loopMatches": [ { "to": 5, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "dc659062-6b4a-4152-86a1-bfaaa43636cd", "evidence": "The document highlights the limitations of current treatments and the need for effective therapies.", "position": 0, "objective": "What is the cost of not developing effective ALS treatments?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 4, "from": 4, "beatId": "d052347b-c66e-4f68-a07d-820ca641582f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the problem of limited ALS treatment options.", "position": 0, "confidence": 0.9, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 5, "from": 4, "beatId": "a6f6d67b-e3b5-4237-8f7f-2d28ca4abd76", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document agitates the problem by highlighting the limitations of current treatments.", "position": 1, "confidence": 0.9, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a list of key benefits to summarize the product's market and clinical position.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/5", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-5", "loopMatches": [ { "to": 5, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "dc659062-6b4a-4152-86a1-bfaaa43636cd", "evidence": "The document highlights the limitations of current treatments and the need for effective therapies.", "position": 0, "objective": "What is the cost of not developing effective ALS treatments?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" }, { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "a6f6d67b-e3b5-4237-8f7f-2d28ca4abd76", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document agitates the problem by highlighting the limitations of current treatments.", "position": 1, "confidence": 0.9, "parentBeatName": "Development", "parentBeatSlug": "development" }, { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "Includes a navigation bar at the bottom indicating the current section is 'PrimeC'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/6", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-6", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "comparison_table", "function": "cite_precedent", "notes": "The slide uses a case study to validate the business/clinical model of combination therapies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/7", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-7", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide uses a bar chart to compare hazard ratios of multiple compounds against a vehicle control, with statistical significance markers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/8", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-8", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": "Uses a chain-link visual metaphor to represent the combination of two distinct therapeutic strategies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/9", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-9", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "Includes a line chart showing PK data and a biological diagram illustrating the mechanism of action (blocking MDR-mediated efflux).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/10", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-10", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "solution", "function": "present_solution", "notes": "The chart highlights the synchronized peak at 5 hours for both active ingredients in the PrimeC formulation compared to reference compounds.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/11", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-11", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological process diagram to illustrate how PrimeC modulates microRNA regulation, TDP-43 aggregation, and cellular recycling.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/12", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-12", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "Includes a bar chart of motor performance and visual evidence of motor neuron recovery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/13", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-13", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 13, "beatId": "634ec05e-3498-46b7-b4f3-93263be96284", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence and proof of PrimeC's effectiveness in clinical trials.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "Includes a progress bar at the bottom indicating the current section is 'Phase 2a Results'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/14", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-14", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 13, "beatId": "634ec05e-3498-46b7-b4f3-93263be96284", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence and proof of PrimeC's effectiveness in clinical trials.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a comparative clinical trial analysis against a historical control database (PRO-ACT).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/15", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-15", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 13, "beatId": "634ec05e-3498-46b7-b4f3-93263be96284", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence and proof of PrimeC's effectiveness in clinical trials.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "Includes a process diagram showing exosome extraction from blood samples.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/16", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-16", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 13, "beatId": "634ec05e-3498-46b7-b4f3-93263be96284", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence and proof of PrimeC's effectiveness in clinical trials.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "Data shows p-values of 0.005 and <0.001 for treated groups, indicating significant biomarker reduction.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/17", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-17", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 13, "beatId": "634ec05e-3498-46b7-b4f3-93263be96284", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence and proof of PrimeC's effectiveness in clinical trials.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a process-flow diagram to link trial results to the next phase of development.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/18", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-18", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 13, "beatId": "634ec05e-3498-46b7-b4f3-93263be96284", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents evidence and proof of PrimeC's effectiveness in clinical trials.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "roadmap", "function": "plan_implementation", "notes": "Includes a progress bar at the bottom indicating the current stage is Phase 2b.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/19", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-19", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 22, "from": 19, "beatId": "5a6a2bde-f57f-473c-9439-f96478df310c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "The document outlines the impact of PrimeC and next steps for the company.", "position": 4, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix", "function": "other", "notes": "The slide uses a numbered list format to categorize four distinct patent filings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/20", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-20", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 22, "from": 19, "beatId": "5a6a2bde-f57f-473c-9439-f96478df310c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "The document outlines the impact of PrimeC and next steps for the company.", "position": 4, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "other", "function": "cite_precedent", "notes": "The slide uses a logo-grid layout to establish credibility through institutional and industry partnerships.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/21", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-21", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 22, "from": 19, "beatId": "5a6a2bde-f57f-473c-9439-f96478df310c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "The document outlines the impact of PrimeC and next steps for the company.", "position": 4, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a color-coded legend for ALS, Alzheimer's, and Parkinson's.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/22", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-22", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 22, "from": 19, "beatId": "5a6a2bde-f57f-473c-9439-f96478df310c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "The document outlines the impact of PrimeC and next steps for the company.", "position": 4, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/23", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-23", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/24", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-24", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "team_bio", "function": "other", "notes": "The slide includes a progress bar at the bottom indicating the current section is 'Summary'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/25", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-25", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix", "function": "other", "notes": "The slide serves as a media/press coverage page, likely for an appendix.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/26", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-26", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes stock price, market cap, cash position, and analyst coverage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/27", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-27", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "executive_summary", "function": "summarize", "notes": "Includes a team photo and a progress bar at the bottom indicating the current slide is the 'Summary' section.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/28", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-28", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/29", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-29", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "other", "function": "inspire_vision", "notes": "This is a highly emotional, narrative-driven slide used to ground the company's mission in a personal story.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/30", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-30", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "traction", "function": "show_traction", "notes": "The chart shows a negative correlation trend line between TDP-43 change and ALSFRS-R slope.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/31", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-31", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/32", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-32", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix", "function": "appendix", "notes": "The slide serves as a press clipping or media coverage appendix.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/33", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-33", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "docSlug": "be407bbae8f9e005c3f7268aea2b4f13", "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 34 slides", "authorId": "neurosense-therapeutics", "authorName": "NeuroSense Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_methodology", "function": "present_framework", "notes": "Includes a navigation bar at the bottom indicating the current section is 'Phase 2b'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-2fc9-715d-b6e1-faa3fd3ed1eb/34", "deckHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb", "deckAnchorHref": "/decks/019de075-2fc9-715d-b6e1-faa3fd3ed1eb#slide-34", "loopMatches": [ { "to": 34, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "c317ff20-e462-4b87-8745-365a96908ee6", "evidence": "The document outlines the development process and clinical trials for PrimeC.", "position": 1, "objective": "What are the key tasks that need to be done to develop PrimeC as a treatment for ALS?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.8, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 34, "from": 5, "beatId": "e49a51a7-5d8f-48c6-bbde-aebd1ab25027", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents PrimeC as a potential solution to the problem of limited ALS treatment options.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3072-74ad-940e-c4e86071ea31", "docSlug": "f24acb01fd30eca71a203358fc871b32", "documentTitle": "Nexters | Investor Presentation Deck | 19 slides", "authorId": "nexters", "authorName": "GDEV", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes a footnote indicating the company was formerly known as Nexters.", "imagePath": "https://imgproxy.kitesheet.com/bdKnRMROshupg_zh4CPlysVvAqXNe7fjSt3XUW7U9ZY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMjRhY2IwMWZkMzBlY2E3MWEyMDMzNThmYzg3MWIzMi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3072-74ad-940e-c4e86071ea31/1", "deckHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31", "deckAnchorHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/Jgv_ht8DaRF5CPAXXCMuRgO_kVxOzWMVkc3vJqnJKig/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMjRhY2IwMWZkMzBlY2E3MWEyMDMzNThmYzg3MWIzMi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/DYWqKl-JC0i_OltNSIJMummy57WOokmvxUPdl8IQqA4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMjRhY2IwMWZkMzBlY2E3MWEyMDMzNThmYzg3MWIzMi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/-3hQgOiBqMKnDYv5xKDXYAapL38Cw7whjPTrFdPsp-k/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMjRhY2IwMWZkMzBlY2E3MWEyMDMzNThmYzg3MWIzMi9wMDAxLnBuZw" }, { "docId": "019de075-3072-74ad-940e-c4e86071ea31", "docSlug": "f24acb01fd30eca71a203358fc871b32", "documentTitle": "Nexters | Investor Presentation Deck | 19 slides", "authorId": "nexters", "authorName": "GDEV", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3072-74ad-940e-c4e86071ea31/2", "deckHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31", "deckAnchorHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3072-74ad-940e-c4e86071ea31", "docSlug": "f24acb01fd30eca71a203358fc871b32", "documentTitle": "Nexters | Investor Presentation Deck | 19 slides", "authorId": "nexters", "authorName": "GDEV", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 3, "slideType": "appendix_disclosure", "function": "appendix", "notes": "Includes definitions for MPUs, ABPPU, Bookings, and Adjusted EBITDA.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3072-74ad-940e-c4e86071ea31/3", "deckHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31", "deckAnchorHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3072-74ad-940e-c4e86071ea31", "docSlug": "f24acb01fd30eca71a203358fc871b32", "documentTitle": "Nexters | Investor Presentation Deck | 19 slides", "authorId": "nexters", "authorName": "GDEV", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a mix of logos, bar charts for financial/user growth, and a pie chart for platform split.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3072-74ad-940e-c4e86071ea31/4", "deckHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31", "deckAnchorHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3072-74ad-940e-c4e86071ea31", "docSlug": "f24acb01fd30eca71a203358fc871b32", "documentTitle": "Nexters | Investor Presentation Deck | 19 slides", "authorId": "nexters", "authorName": "GDEV", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 5, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide uses a grid of icons to highlight six key pillars of the company's competitive advantage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3072-74ad-940e-c4e86071ea31/5", "deckHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31", "deckAnchorHref": "/decks/019de075-3072-74ad-940e-c4e86071ea31#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }